Biogen License definition
Examples of Biogen License in a sentence
Genentech shall use its Best Efforts to keep the CMCC License and the Biogen License in effect during the term of this Agreement, *** .
Interferon D3 (as that term is defined in the Biogen License) in the Territory (excluding Japan) in the fields of: (i) scleroderma and (ii) infectious disease or condition caused by human papillomavirus.
This Agreement shall commence on the Effective Date of this Agreement and, unless terminated earlier, shall expire at the later to occur of (a) the expiration of the last to expire of any Genentech Patent Rights or (b) twenty (20) years from the Effective Date of this Agreement; provided, however, that in the event that either the […***…] License or the Biogen License is terminated, the licenses granted by Genentech to Connetics under the […***…] License or the Biogen License shall also terminate.
Genentech shall use its Best Efforts to keep the […***…] License and the Biogen License in effect during the term of this Agreement, provided, however, that if Connetics declines to pay a […***…] benchmark payment as outlined in Section 5.2(c) or pay any royalty owed to […***…] under the […***…] License for the sales of Licensed Products, then Genentech shall not be obligated to make such payment and Genentech shall have the option, in its sole discretion, to terminate the […***…] License.
The Parties agree, however, that in no event will the royalty due Pharming on the sales of such transgenic cattle, and/or the proteins produced in such transgenic cattle, as applicable, ever exceed six percent (6%) in total under this Agreement and the Biogen License.
Biogen has exercised its Option (as defined in the 2012 Biogen License) with respect to Spinraza in accordance with Section 3.1.3 of the 2012 Biogen License and in accordance with the timeline set forth therein.
The Seller has not received any notice from Biogen pursuant to Section 4.1.2 of the 2012 Biogen License or Section 4.1.2 of the 2017 Biogen License.
To the Knowledge of the Seller, no event or condition exists that, upon notice or passage of time or both, would reasonably be expected to permit Biogen to claim, or have the right to claim, a Royalty Reduction (including any BIIB-115 Permitted Reduction) against the BIIB-115 Royalty (other than as contemplated by Section 6.6.2(c) of the 2017 Biogen License).
The Spinraza Assigned Patents were assigned to Biogen in accordance with Section 4.2 of the 2012 Biogen License.
The Seller has not developed any Follow-On Compound (as defined in the 2012 Biogen License) and Biogen has not exercised its right of first negotiation to develop and commercialize any Follow-On Compound pursuant to Section 2.1.2 of the 2012 Biogen License, except for BIIB-115.